Core Laboratories: Not a Buy Yet, But Still Worth Holding On
CLB expands globally with new tech labs and energy transition projects while reducing debt but faces tariff pressures, U.S. market softness and demand volatility risks.
Zacks·28d ago
More News
Core Laboratories (CLB) Down 21.7% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·1mo ago
Expand Energy Q2 Earnings & Revenues Miss Estimates, Both Increase Y/Y
EXE's Q2 2025 earnings and revenues miss estimates, but increase year over year, driven by strong production and higher natural gas price realization.
Zacks·2mo ago
Liberty Energy Q2 Earnings Miss, Sales Beat Estimates, Both Fall Y/Y
LBRT's second-quarter earnings miss estimates and fall year over year, due to increased macroeconomic uncertainty and energy sector volatility.
CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.
Zacks·2mo ago
Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss?
Here's a preview of what to expect from energy stocks EQNR, CLB, OII and PTEN ahead of their quarterly earnings reports, set to be released tomorrow.
Zacks·2mo ago
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch
CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.
Zacks·2mo ago
Do Options Traders Know Something About Core Laboratories Stock We Don't?
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Zacks·3mo ago
Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?
CLB struggles with declining revenues, geopolitical risks, margin compression and weak U.S. demand, creating uncertainty around growth and profitability prospects.
Zacks·3mo ago
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock?